Neil Garg
Overview
Explore the profile of Neil Garg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shover C, Godvin M, Appley M, Pyfrom E, Castrillo F, Hochstatter K, et al.
JAMA
. 2025 Feb;
PMID: 39908044
No abstract available.
2.
Abdul-Rahman T, Roy P, Ahmed F, Mueller-Gomez J, Sarkar S, Garg N, et al.
Eur J Pharmacol
. 2024 Nov;
985:177095.
PMID: 39515565
The increasing prevalence of obesity and type 2 diabetes mellitus has resulted in a significant challenge to public health throughout the globe. It required the development of novel therapeutic approaches....
3.
Abdul-Rahman T, Ghosh S, Badar S, Nazir A, Bamigbade G, Aji N, et al.
Eur J Med Res
. 2024 Feb;
29(1):124.
PMID: 38360737
Tumor progression and eradication have long piqued the scientific community's interest. Recent discoveries about the role of chemokines and cytokines in these processes have fueled renewed interest in related research....
4.
Abdul-Rahman T, Ghosh S, Kalmanovich J, Awuah A, Zivcevska M, Khalifa S, et al.
J Neurosci Res
. 2024 Jan;
102(1):e25261.
PMID: 38284858
Membrane trafficking is a physiological process encompassing different pathways involved in transporting cellular products across cell membranes to specific cell locations via encapsulated vesicles. This process is required for cells...
5.
Abdul-Rahman T, Lizano-Jubert I, Bliss Z, Garg N, Meale E, Roy P, et al.
Prog Cardiovasc Dis
. 2024 Jan;
85:93-102.
PMID: 38253161
Personalized medicine has witnessed remarkable progress with the emergence of RNA therapy, offering new possibilities for the treatment of various diseases, and in particular in the context of cardiovascular disease...
6.
Abdul-Rahman T, Bliss Z, Lizano-Jubert I, Munoz M, Garg N, Pachchipulusu V, et al.
Curr Probl Cardiol
. 2024 Jan;
49(3):102378.
PMID: 38185434
Coronary Artery Disease (CAD) represents a persistent global health menace, particularly prevalent in Eastern European nations. Often asymptomatic until its advanced stages, CAD can precipitate life-threatening events like myocardial infarction...
7.
Abdul-Rahman T, Lawal L, Meale E, Ajetunmobi O, Toluwalashe S, Alao U, et al.
J Med Virol
. 2023 Aug;
95(8):e28986.
PMID: 37534818
The Ebola virus, a member of the filoviridae family of viruses, is responsible for causing Ebola Virus Disease (EVD) with a case fatality rate as high as 50%. The largest...
8.
Abdul-Rahman T, Lizano-Jubert I, Garg N, Talukder S, Lopez P, Awuah W, et al.
Prog Cardiovasc Dis
. 2023 Jun;
79:89-99.
PMID: 37302652
Calcific aortic valve stenosis (CAS), the most prevalent valvular disease worldwide, has been demonstrated to frequently occur in conjunction with coronary artery disease (CAD), the third leading cause of death...
9.
Rosenzveig A, Garg N, Rao S, Kanwal A, Kanwal A, Aronow W, et al.
Expert Opin Pharmacother
. 2023 Jun;
24(12):1349-1360.
PMID: 37272195
Introduction: Hypertrophic cardiomyopathy (HCM) is one of the most common genetic causes of heart disease. Since the initial description of HCM, there have been minimal strides in management options. Obstructive...
10.
Abdul-Rahman T, Lizano-Jubert I, Garg N, Tejerina-Marion E, Bukhari S, Luisa Ek A, et al.
Healthcare (Basel)
. 2023 Apr;
11(8).
PMID: 37107928
In the United States, about one million people are seen to visit the operating theater for cardiac surgery annually. However, nearly half of these visits result in complications such as...